- Home
- AMPY vs NRXP Comparison
AMPY vs NRXP Comparison
Compare AMPY & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AMPY | NRXP |
|---|---|---|
| Founded | 2011 | 2015 |
| Country | United States | United States |
| Employees | N/A | 29 |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 215.9M | 181.5M |
| IPO Year | 2011 | N/A |
Fundamental Metrics
Financial Performance| Metric | AMPY | NRXP |
|---|---|---|
| Price | $3.96 | $3.78 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $38.25 |
| AVG Volume (30 Days) | ★ 857.7K | 784.5K |
| Earning Date | 05-06-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 232.26 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $208,637,000.00 | N/A |
| Revenue This Year | N/A | $2,547.84 |
| Revenue Next Year | $23.83 | $1,591.73 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.41 | $1.65 |
| 52 Week High | $6.79 | $5.06 |
Technical Indicators
Market Signals| Indicator | AMPY | NRXP |
|---|---|---|
| Relative Strength Index (RSI) | 41.82 | 44.81 |
| Support Level | $3.86 | $2.90 |
| Resistance Level | $4.23 | $4.20 |
| Average True Range (ATR) | 0.15 | 0.32 |
| MACD | 0.04 | -0.03 |
| Stochastic Oscillator | 26.49 | 0.95 |
Price Performance
Historical ComparisonAbout AMPY Amplify Energy Corp.
Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The companies oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana and Eagle Ford.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.